Literature DB >> 31391811

Idiopathic Noncirrhotic Portal Hypertension.

Harry L A Janssen1.   

Abstract

Entities:  

Year:  2019        PMID: 31391811      PMCID: PMC6676350     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


× No keyword cloud information.
  5 in total

1.  Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study.

Authors:  J N L Schouten; F Nevens; B Hansen; W Laleman; M van den Born; M Komuta; T Roskams; J Verheij; H L A Janssen
Journal:  Aliment Pharmacol Ther       Date:  2012-04-27       Impact factor: 8.171

Review 2.  Idiopathic noncirrhotic portal hypertension.

Authors:  Jeoffrey N L Schouten; Juan C Garcia-Pagan; Dominique C Valla; Harry L A Janssen
Journal:  Hepatology       Date:  2011-07-21       Impact factor: 17.425

3.  Obliterative portal venopathy: portal hypertension is not always present at diagnosis.

Authors:  Dominique Cazals-Hatem; Sophie Hillaire; Marika Rudler; Aurélie Plessier; Valerie Paradis; Bertrand Condat; Claire Francoz; Marie-Hélène Denninger; François Durand; Pierre Bedossa; Dominique C Valla
Journal:  J Hepatol       Date:  2010-10-28       Impact factor: 25.083

4.  Extrahepatic portal vein thrombosis: aetiology and determinants of survival.

Authors:  H L Janssen; A Wijnhoud; E B Haagsma; S H van Uum; C M van Nieuwkerk; R P Adang; R A Chamuleau; J van Hattum; F P Vleggaar; B E Hansen; F R Rosendaal; B van Hoek
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

5.  Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension.

Authors:  Julien Bissonnette; Juan Carlos Garcia-Pagán; Agustín Albillos; Fanny Turon; Carlos Ferreira; Luis Tellez; Jean-Charles Nault; Nicolas Carbonell; Jean-Paul Cervoni; Mohamed Abdel Rehim; Annie Sibert; Louis Bouchard; Pierre Perreault; Jonel Trebicka; Félix Trottier-Tellier; Pierre-Emmanuel Rautou; Dominique-Charles Valla; Aurélie Plessier
Journal:  Hepatology       Date:  2016-05-13       Impact factor: 17.425

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.